Test Price
2,800 AED✅ Home Collection Available
NEUROG3 Gene Genetic Test for Congenital Diarrhea Type 4 (Malabsorptive) | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation and genetic counselling.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NEUROG3 gene NGS test detects pathogenic variants in the NEUROG3 gene, which is responsible for congenital malabsorptive diarrhea type 4 – a severe neonatal enteropathy leading to life-threatening dehydration and electrolyte imbalances. This test provides molecular confirmation for targeted nutritional and clinical management, and it is essential for infants and children with intractable diarrhea of unknown etiology.
| Feature | Our NEUROG3 NGS Test | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity | ~95% per variant, may miss deep intronic mutations |
| Methodology | Next Generation Sequencing (NGS) with full gene coverage | Sanger sequencing for selected exons |
| Turnaround Time | 3 - 4 Weeks | 6 - 8 Weeks |
Physician Insight & Safety Protocols
“The NEUROG3 genetic test provides definitive molecular confirmation for congenital diarrheal disorders. A positive result must be correlated with clinical and histopathological findings to guide complex nutritional rehabilitation and long-term care. Multidisciplinary team involvement is essential to ensure optimal outcomes for your child.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Important Medication Advisory
Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Always inform your genetic counsellor about all medications and supplements before testing.
Exclusion Criteria & ER Red Flags
- This test is not indicated for acute infectious gastroenteritis or self-limiting diarrheal episodes.
- Patients must first undergo thorough clinical and metabolic evaluation to exclude common causes of malabsorption.
- Genetic counselling is mandatory before sample collection; a pedigree chart must be reviewed.
- Seek emergency care immediately if the patient develops severe dehydration, lethargy, intractable vomiting, or shock.
Patient FAQ & Clinical Guidance
1. Who should consider the NEUROG3 gene NGS test?
Infants or children with congenital, intractable, malabsorptive diarrhea of unknown cause, especially when parenteral nutrition is required. This test is also recommended for families with a history of neonatal diarrheal disorders.
2. How accurate is this NEUROG3 Genetic Test?
This NGS-based test provides >99.9% analytical sensitivity and specificity for all known pathogenic variants in the NEUROG3 gene. Confirmatory Sanger sequencing is performed for all reported variants.
3. What sample is needed and how is the collection done in the UAE?
A single blood drop on an FTA card, whole blood, or extracted DNA is accepted. Our VIP Mobile Phlebotomy service visits your home daily from 8 AM to 11 PM, using temperature-controlled cold-chain transport to the laboratory.
UAE Regulatory & Data Privacy Adherence
Legal Framework & Compliance
- All testing is conducted under the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient safety and informed consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Personal health information is safeguarded per UAE PDPL and DHA data privacy regulations.
Clinical & Logistical Metadata
| Test Name | NEUROG3 Gene Genetic Test for Congenital Diarrhea Type 4 (Malabsorptive) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 - 4 Weeks |
| Sample Type / Matrix | Whole Blood, FTA Card, or Extracted DNA |
| Methodology Used | Next Generation Sequencing (NGS) with full gene coverage & confirmatory Sanger sequencing |
| ICD-10-CM Code | P78.2, Q43.8, Z13.79 |
| LOINC Code | 53385-3 |
| DHA Facility License & Laboratory Address | DNA Labs UAE | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians